HYCOR BIOMEDICAL INC /DE/
S-8, EX-5, 2000-09-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: HYCOR BIOMEDICAL INC /DE/, S-8, EX-4, 2000-09-01
Next: HYCOR BIOMEDICAL INC /DE/, S-8, EX-23.1, 2000-09-01



<PAGE>   1

                                    EXHIBIT 5

                      Paul, Hastings, Janofsky & Walker LLP
       A Limited Liability Partnership including Professional Corporations
                                Seventeenth Floor
                              695 Town Center Drive
                        Costa Mesa, California 92626-1924
                                 (714) 668-6200


September 1, 2000

Hycor Biomedical Inc.
7272 Chapman Avenue
Garden Grove, California 92841

Re:     Hycor Biomedical Inc.
        2000 Employee Stock Purchase Plan
        Registration Statement Form S-8

Ladies and Gentlemen:

We are furnishing this opinion in connection with the preparation and filing
with the Securities and Exchange Commission of a Registration Statement on Form
S-8 (the "Registration Statement") registering 300,000 shares of Hycor
Biomedical Inc.'s (the "Company") common stock, par value $0.01 per share (the
"Common Stock"), for issuance under the Company's 2000 Employee Stock Purchase
Plan (the "Plan").

We have examined such records and documents and made such examination of law as
we have deemed relevant in connection with this opinion. Based on the foregoing,
we are of the opinion that the 300,000 shares covered by such Registration
Statement, when issued in accordance with the terms of the Plan and the
Prospectus forming a part of the Registration Statement, will be legally issued,
fully-paid and nonassessable.

We hereby consent to the filing of this opinion as an exhibit to the
above-referenced Registration Statement.

Respectfully submitted,

/s/ PAUL, HASTINGS, JANOFSKY & WALKER LLP

Paul, Hastings, Janofsky & Walker LLP



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission